The total number of people living in the US with
std is over sixty-five million. Every year, there are
approximately fifteen million new STD cases. Sexually
transmitted diseases (STDs) are infections (infectious diseases)
that a person can get from someone who has the infection (active
and non-active) during sex. The three main groups of
micro-organisms that cause
stds are bacteria, viruses and parasites. These infections are
usually passed by having vaginal intercourse, but they can also be
passed through anal sex, oral sex or skin-to-skin
contact.
Determinants of evolving epidemics of sexually transmitted
diseases (STD) are equally influenced by the evolution of the STD
epidemics themselves and by the evolution of human societies. A
temporal approach to STD transmission dynamics suggests the need to
monitor infectivity, rate of exposure between infected and
susceptible individuals, and duration of infectiousness in
societies. Different indicators may be used to monitor rate of
exposure in the general population and in core groups. In addition,
underlying determinants of STD epidemics such as poverty,
inequality, racial/ethnic discrimination, unemployment, and sex
ratio, volume of migration, and health care coverage and quality
are important variables to monitor through a surveillance system
focused on social context. Ongoing large scale societal changes
including urbanization, globalization, increasing inequality, and
increasing volume of migrant populations may affect the evolution
of STD epidemics. Globalised STD epidemics could pose a major
challenge to local public health systems.
There are more than a dozen of different kinds of common
STDs.
Most STDs affect both men and women, but in
many cases the health problems they cause can be more severe for
women. If a pregnant woman has an STD, it can cause serious health
problems for the baby.
Injection drug use is inextricably linked to commercial sex work
and the transmission of sexually transmitted disease (STD). In many
communities prevention efforts have been stalled owing to the
marginal existence of this community. This study describes the
sexual activities, condom use, reported STDs, and commercial sex
work in a large cohort of injection drug users. Seventy two per
cent of male and 92% of female subjects in the cohort were sexually
active. Among female subjects, 57% reported more than 100 lifetime
partners. Condoms were generally not used with regular partners,
used about half the time with casual partners, and used about 80%
of the time with paying partners. Female sex workers were more
likely to have unstable housing and to report incarceration in the
previous six months. Reducing the transmission of STDs and HIV in
drug using communities is a public health priority. While existing
prevention programs should be strengthened, innovative approaches
to STD surveillance, diagnosis, and prevention are needed.
- Itching around the vagina and/or discharge from
the vagina for women
-
discharge from the penis for men and vaginal
discharge for women
- Pain during sex or when urinating
- Pain in the pelvic area
- Sore throats in people who have oral sex
- Pain in or around the anus for people who have anal sex
- Chancre sores (painless red sores) on the genital area, anus,
tongue and/or throat
- A scaly rash on the palms of your hands and the soles of your
feet
- Dark urine, loose, light-colored stools, and yellow eyes and
skin
- Small blisters that turn into scabs on the genital area
- Swollen glands, fever and body aches
- Unusual infections, unexplained fatigue, night sweats and
weight loss
- Soft, flesh-colored warts around the genital area
Chlamydia, Gonorrhea, Chancroid, Trichomoniasis,
bacterial vaginosis (BV), and Genital Herpes
std treatment is indicated for sex partners if the last sexual
encounter was within 60 days.
std treatment of Chlamydia is indicated for patients being
treated for Gonorrhea, and vice versa. (It is common to have these
two STD infections together) If STD diagnosis is not confirmed,
then empiric triple antibiotic
std treatment is advocated for the most common STDs -
chlamydia treatment, gonorrhea, and trichomoniasis. Triple STD
antibiotic regimen: Doxycycline 100 mg twice a day / 10 days; Cipro
XR 500mg or 1000mg one single dose (or Levaquin, or Tequin); and
Metronidazole 500 mg twice a day for 10 days.
Tags: chancroid
chlamydia
crabs gonorrhea
hepatitis
herpes hiv aids
hpv warts
scabies
std treatment
stds syphilis
trichomoniasis
vaginal
yeast vaginosis
bv yeast in
men
doxycycline is a member of the tetracycline antibiotics group
and is commonly used to treat a variety of infections.
doxycycline is a semi-synthetic tetracycline invented and
clinically developed in the early 1960s by Pfizer Inc. and marketed
under the brand name Vibramycin. Vibramycin received FDA approval
in 1967, becoming Pfizer's first once-a-day broad-spectrum
antibiotic. Other brand names include Monodox, Periostat,
Vibra-Tabs, Doryx, Vibrox, Adoxa, Doxyhexal and Atridox (topical
doxycycline hyclate for Periodontitis).
Evidence of an STD-HIV interaction and the availability of
noninvasive urine-based screening tests have resulted in an
increased focus on Chlamydia infections in men. Gonorrhea was
identified in 45% of men who have sex with men (MSM) versus 26% of
men who have sex with women (MSW). Among men with gonorrhea,
chlamydia co infection was found among 15.2% of MSM and 8.4% of
MSW. Among men with nongonococcal urethritis, 18% and 20% of MSM
and MSW had Chlamydia infection, respectively. Young age was
associated with Chlamydia infection in MSM. After a period of low
Chlamydia infection rates in MSM during the pre-AIDS era, infection
rates are increasing among this population. SFCC's revised clinical
practice guidelines include chlamydia testing of MSM with
urethritis.
Ciprofloxacin (aka
cipro) is the generic international name for the synthetic
antibiotic manufactured and sold by Bayer A.G. under the brand
names
cipro, ciproxin and ciprobay (and other brand names in other
markets, e.g. veterinary medicine), belonging to a group called
fluoroquinolones. Ciprofloxacin (cipro)
is bacteriocidal. Its mode of action depends upon blocking
bacterial DNA replication by binding itself to an enzyme called DNA
gyrase, thereby causing double-stranded breaks in the bacterial
chromosome.
Metronidazole is a nitroimidazole anti-infective medication used
mainly in the treatment of infections caused by susceptible
organisms, particularly anaerobic bacteria and protozoa. It is
marketed by Pfizer under the trade name Flagyl in the US, while
Sanofi-Aventis markets
metronidazole globally under the same tradename, Flagyl, and
also by various generic manufacturers, who sell it at a lower
price.
metronidazole is also used as a gel preparation in the
treatment of the dermatological conditions such as rosacea (Rozex
and Metro-Gel by Galderma) and fungating tumours (Anabact,
Cambridge Healthcare Supplies).
Metronidazole is a prodrug. It is converted in anaerobic
organisms by the redox enzyme pyruvate-ferredoxin oxidoreductase.
The nitro group of
metronidazole is chemically reduced by ferredoxin (or a
ferredoxin-linked metabolic process) and the products are
responsible for disrupting the DNA helical structure, thus
inhibiting nucleic acid synthesis.
Metronidazole is selectively taken up by anaerobic bacteria and
sensitive protozoal organisms because of the ability of these
organisms to reduce
metronidazole to its active form intracellularly.
Tags: std treatment chancroid lice syphilis std symptoms
chlamydia gonorrhea trichomoniasis std information herpes
scabies crabs std treatment yeast infection hepatitis hpv std info
warts yeast in men vaginosis stds pics lice hiv aids std
pictures
Tags: chancroid
chlamydia
crabs gonorrhea
hepatitis
herpes hiv aids
hpv warts
scabies
std treatment
stds syphilis
trichomoniasis
vaginal
yeast vaginosis
bv yeast in
men
Medical records of 341 patients with syphilis seen at a health
department sexually transmitted disease clinic were reviewed to
assess membership in high-risk subgroups and interactions with
human immunodeficiency virus (HIV) infection. When compared with
the entire clinic population, patients with syphilis tended to be
older and were more likely to acknowledge intravenous drug use,
more often had a history of syphilis, and, among men, were more
often homosexually active. Half of the men with syphilis and one
third of the women fell into one or more of these high-risk
subgroups. Patients with syphilis were also more likely to test
positive for HIV infection than other patients attending the
clinic. Patients admitting to intravenous drug use, prior syphilis,
or being homosexually active were significantly more likely to be
HIV seropositive than patients without these characteristics, even
though patients with these characteristics were significantly more
likely to refuse HIV serologic testing. Although clinical stage of
syphilis at presentation did not differ when patients with and
without concurrent HIV infection were compared, geometric mean
rapid plasma reagin titers were significantly higher in
HIV-infected patients with secondary syphilis.
If
STD diagnosis is not confirmed, then empiric triple antibiotic
std treatment is advocated for the most common STDs -
Chlamydia, Gonorrhea, and Trichomoniasis. Triple STD antibiotic
regimen: Doxycycline 100 mg twice a day / 10 days; Cipro® XR 500mg
or 1000mg one single dose (or Levaquin®, or Tequin®); and
Metronidazole 500 mg twice a day for 10 days.
Tags: chancroid
chlamydia
crabs
gonorrhea
hepatitis
herpes
hiv aids
hpv warts
scabies
std
treatment stds
syphilis
trichomoniasis
vaginal
yeast vaginosis
bv yeast in
men std pictures, std symptoms, std information, std treatment,
std info, stds pics, chancroid,
chlamydia, crabs, lice, gonorrhea, hepatitis, herpes, hiv, aids,
hpv, warts, scabies, syphilis,
trichomoniasis, yeast infection, vaginosis, yeast in men
STD-GOV.org -
std
STD-GOV.org -
std